Search PubMed⌕ Search

Biomedical subjects

A Lachaux

Publications and source records attributed to A Lachaux.

At least 73 records · Page 4Linked to original sources

Familial autoimmune enteropathy with circulating anti-bullous pemphigoid antibodies and chronic autoimmune hepatitis.

In a family of four children (two boys and two girls), the two brothers had severe, protracted watery diarrhea beginning at 2 and 3 weeks of life, respectively. Duodenal mucosa in both patients showed total villous atrophy and severe inflammatory infiltration of the entire bowel. The first patient also had lymphoid cell infiltration of the pancreas and died at 6 weeks of age. The second boy is alive at 2 years of age and is immunocompetent, but still receives total parenteral nutrition. Indirect immunofluorescence studies revealed circulating antibodies to enterocytes, smooth muscle, thyroid, and islet cells. Bullous pemphigoid antibodies (230 and 180 kd), specific for hemidesmosomal proteins and usually associated with a subepidermal blistering skin disease, were detected by direct and indirect immunofluorescence studies and by Western immunoblot. A diagnosis of autoimmune hepatitis was made, based on evidence of chronic active hepatitis and circulating anti-smooth muscle antibody. Immunosuppressive treatments induced partial clinical remission of the diarrhea but no resolution of the small bowel injury. At 16 months of age, remission of the diarrhea occurred, but persistent autoimmune hepatitis led us to maintain treatment with prednisone and azathioprine, and later with cyclosporine. In this child, as in other patients with autoimmune disease, the link between autoantibodies and organ damage remains uncertain but immunosuppressive treatment is indicated.

Autoantibodies↗

Recombinant human G-CSF (Lenograstim) for infectious complications in glycogen storage disease type Ib. Report of 7 cases.

Seven patients with glycogen storage disease type Ib suffering from severe and/or recurrent bacterial infections were treated with glycosylated recombinant G-CSF (Lenograstim). Mean follow up was 20.8 months (range 9-30 months). In all cases a median dose of 5 micrograms/kg/day resulted in rapid clinical improvement, associated in 6/7 with an increase in absolute polymorphonuclear (PMN) count. In the remaining subject, a striking amelioration of infectious status contrasted with a persistently low PMN count. Liver transplantation in one patient resolved metabolic complications but did not improve PMN count or the infectious status, while neutropenia was corrected by G-CSF. Prevention of recurrent infections was achieved in all cases with intermittent therapy. Short term treatment was well tolerated, thrombocytopenia in two patients (WHO grade 0 and grade 3) recovering after decrease of G-CSF dosage.

Adolescent↗

[Home parenteral nutrition in children: practical modalities].

Today, the duration of parenteral nutrition (PN) is unlimited. PN is used in digestive tract chronic disease (the digestive tract is either unusable or is at rest) or in oncology, hematology and renutrition before transplantation. Thanks to technical advances, PN, although sophisticated, may be applied at home if an active involvement of one parent is obtained. Home PN is indicated when it is planned for more than 3 months. The indications as a function of the disease, socio-cultural background and the distance to the PN centre are reviewed. The technical modalities such as vascular access, the choice of a catheter, the nutriments to be perfused, the parents' training and the logistic support are studied. Complications of home PN are identical to those of prolonged PN; infections is the most frequent. Results of PN as well as the quality of life of the children are briefly reported.

Adolescent↗

[Common bilio-pancreatic channel. Apropos of a case with intermittent dilatation of the biliary tracts].

BACKGROUND: A common biliopancreatic channel can be revealed by cholestatic episodes. Its early removal avoids the development of liver cirrhosis and the risk of carcinomatous change. CASE REPORT: A 2 year 9 month-old girl had suffered from jaundice plus dark urine and pale stools for 2 months. A similar episode occurred 7 months later. Ultrasonography showed moderate dilatation of the intra and extrahepatic bile ducts that disappeared a few weeks later. A third episode of cholestasis with moderate dilation of the bile ducts occurred at the age of 3 year 11 months, complicated 2 weeks later by abdominal pain, vomiting and abdominal distension. Her serum amylase activity was 1,380 IU/l (N < 82). Ultrasonography and CT scan showed moderate dilation of the common hepatic duct. Liver biopsy showed pathological features consistent with bile obstruction. Endoscopic retrograde choledocopancreatography showed a long common channel with dilated extra and intrahepatic bile ducts, an incomplete pancreas divisum and numerous intracanalar stones. A sphincterotomy was performed and stones were extracted. The patient is well 18 months after surgery, with normal laboratory and ultrasonographic profiles. CONCLUSION: A common biliopancreatic channel is often associated with choledocal cyst. Whether development of the cyst is preceded by intermittent dilation of the bile ducts, as in this case, remains to be determined.

Bile Ducts↗

Treatment with lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) and orthotopic liver transplantation for glycogen storage disease type Ib.

A 7 1/2-year-old patient with glycogenosis type lb had chronic neutropenia, recurrent bacterial infections, and severe hypoglycemia in spite of continuous nasogastric feeding. She was treated with lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) and orthotopic liver transplantation. Absolute neutrophil counts and platelet counts rapidly reached normal values, and infectious episodes were reduced. She resumed oral feeding after transplantation and had no subsequent hypoglycemic episodes.

Adjuvants, Immunologic↗

Intestinal epithelial cells express the CD23/Fc epsilon RII molecule: enhanced expression in enteropathies.

Immunohistochemical analysis of normal human intestine revealed that two anti-CD23 monoclonal antibodies (mAb), EBVCS 1 and EBVCS 2, reacted with human intestinal epithelial cells. Both mAb exhibited an exclusive reactivity with epithelial cells of the small and large bowels. Staining with both EBVCS 1 and EBVCS 2 was localized on the apical and basal sides of enterocytes. Enhanced expression of CD23 on gut epithelial cells was found in inflammatory bowel diseases, in children with food intolerance to cows' milk proteins and in a young infant with severe autoimmune enteropathy. Western blot analysis of anti-CD23 mAb reactivity with gut epithelial cell extracts showed the presence of a non-reducible 42,000-45,000 M(r) polypeptide compatible with the membrane form of the intact CD23 molecule. These data show that CD23 is constitutively expressed by intestinal epithelial cells and that its expression is enhanced in enteropathies.

Antibodies, Monoclonal↗

[CD23: structures, functions and practical perspectives in allergy reactions].

CD23, the low-affinity receptor for IgE, is a surface cell marker and surface CD23 is cleaved into soluble fragments by an autocatalytic mechanism. cDNA clone encoding for CD23 has been isolated and structural studies realized. CD23 is expressed by B and T lymphocytes and by other cells including tumor cells. IL4 and IgE are the most potent inducer of CD23 expression. CD23 has multiple functions: B cell growth and differentiation, capacity to present antigen, cellular mobility, inflammation... The serum sCD23 level is often increased in allergic patients.

Cell Membrane↗

Benign recurrent cholestasis with normal gamma-glutamyl-transpeptidase activity.

We report two observations of intrahepatic cholestasis with normal serum levels of gamma-glutamyl-transpeptidase. These cases fit the diagnostic criteria of benign recurrent cholestasis and show that it, like Byler disease, is another form of pediatric intrahepatic cholestasis with a normal gamma-glutamyl-transpeptidase level in the infant.

Child↗

[Neonatal gastric necrosis].

BACKGROUND: Neonatal necrotizing gastritis is rare. It is usually a complication of acute anoxia or shock and its diagnosis is essentially radiological. CASE REPORTS: Case no. 1: a boy was born at the 36th week of a pregnancy complicated by preeclampsia. Perinatal asphyxia necessitated delivery by cesarean section. He presented with neonatal respiratory distress which was complicated by pneumothorax. On the 5th day of life, the abdomen was distended and the newborn had still not been fed. On the 6th day, X-rays showed pneumatosis of the gastric wall associated with pneumoperitoneum. Surgery showed an area of necrosis on the posterior surface of the stomach with a small perforation, which was stitched. The child was fed 5 days later and was in good condition at the age of 6 months. Case no. 2: a girl was born at the 35th week of a pregnancy complicated by asthma during the second trimester. Perinatal asphyxia and abnormal fetal rhythm led to delivery by cesarean section. At 24 hour of life, she vomited blood and fibroscopy confirmed the presence of blood in the stomach. On the 3rd day, blood vomiting appeared again, associated with abdominal distension. X-rays showed pneumatosis of the gastric wall; fibroscopy showed necrosis of the lower 2/3 of the stomach. Feeding was stopped and the child was given cimetidine. Refeeding was possible when the girl was 10 days old, and she was in good condition at the age of 6 months. CONCLUSION: Neonatal gastric necroses and necrotizing enterocolitis have many similar features. Medical therapy is often effective, but surgery is mandatory when necrotizing gastritis is complicated by perforation.

Female↗

[Autoimmune hepatitis in children].

Autoimmune hepatitis is one of the major etiologies of chronic hepatitis in children. Chronic hepatitis may present with numerous hepatic clinical manifestations, associated with extrahepatic disorders. The etiology is unknown and the disease is characterized by the auto-antibody pattern and the positive response to immunosuppressive treatment.

Autoimmune Diseases↗

[Interleukin 1 receptor antagonists].

Interleukin 1 (IL-1) is a polypeptide cytokine produced by various cell types that mediates a broad range of biological activities and possesses a wide spectrum of immunologic and non immunologic properties. Interest has recently focussed on the role of IL-1 as an inflammatory mediator in chronic and acute diseases. The production of IL-1 inhibitors may be a part of a homeostatic mechanism regulating IL-1 effect on immune and inflammatory cell function. Recent reports concerning the purification, characterization, and expression of a cDNA for an IL-1 receptor antagonist (IL-1ra) have been published. Further study of this protein should be valuable in determining the role of IL-1a in man. The protein should also be useful for studying the list of IL-1 activities. Finally, IL-1a is a potentially useful therapeutic agent for the treatment of IL-1-mediated disease in man.

Humans↗